8 webinars results for

products are one of the most common non-viral vectors, frequently used in both in vivo and ex vivo gene

Whereas, viral vectors can serve as vehicles to deliver therapeutic genes to treat monogenic disorders

Director of Platform R&D Department, manages the platform R&D department to develop antibody, protein, and gene

screening for both IgG and VHH antibody, and HTP cell-to-antibody conversion system without sequencing or gene

delivery and extensive understanding of drug development to help you get your own success. 14 weeks from gene

Pre-clinical through clinical to commercial supply, ProBio is marching forward to support more cell and gene

platform process R&D department to develop process R&D platforms based on antibodies, proteins, and gene

Li was an R&D Manager in MilliporeSigma (USA), leading the development of the company’s Gene Therapy